SEL1L preserves CD8+ T-cell survival and homeostasis by fine-tuning PERK signaling and the IL-15 receptor-mediated mTORC1 axis

被引:0
|
作者
Yafeng Gao
Wenhui Li
Zhenghao Wang
Cangang Zhang
Yaping He
Xiaowei Liu
Kexin Tang
Weiguo Zhang
Qiaoming Long
Yong Liu
Jinping Zhang
Baojun Zhang
Lianjun Zhang
机构
[1] Chinese Academy of Medical Sciences & Peking Union Medical College,National Key Laboratory of Immunity and Inflammation, Suzhou Institute of Systems Medicine
[2] Chinese Academy of Medical Sciences & Peking Union Medical College,Key Laboratory of Synthetic Biology Regulatory Elements, Suzhou Institute of Systems Medicine
[3] China Pharmaceutical University,School of Life Science and Technology
[4] Xi’an Jiaotong University,Department of Pathogenic Microbiology and Immunology, School of Basic Medical Sciences
[5] Xi’an Jiaotong University Health Science Center,Institute of Infection and Immunity, Translational Medicine Institute
[6] Xi’an Jiaotong University,Key Laboratory of Environment and Genes Related to Diseases
[7] Xi’an Key Laboratory of Immune Related Diseases,Department of Radiotherapy and Oncology
[8] The Second Affiliated Hospital of Soochow University,Department of Endocrinology
[9] The Second Affiliated Hospital of Soochow University,Jiangsu Key Laboratory of Neuropsychiatric Diseases and Cam
[10] Medical College of Soochow University,Su Mouse Genomic Resources Center
[11] Wuhan University,Hubei Key Laboratory of Cell Homeostasis, College of Life Sciences, TaiKang Center for Life and Medical Sciences, The Institute for Advanced Studies, Frontier Science Center for Immunology and Metabolism
[12] Soochow University,Institute of Biology and Medical Sciences (IBMS)
来源
关键词
T-cell homeostasis; Endoplasmic reticulum-associated degradation; ER stress response; PERK; IRE1α;
D O I
暂无
中图分类号
学科分类号
摘要
SEL1L-mediated endoplasmic reticulum-associated degradation (ERAD) plays critical roles in controlling protein homeostasis by degrading misfolded or terminal unfolded proteins. However, it remains unclear how SEL1L regulates peripheral T-cell survival and homeostasis. Herein, we found that SEL1L deficiency led to a greatly reduced frequency and number of mature T cells, which was further validated by adoptive transfer experiments or bone marrow chimera experiments, accompanied by the induction of multiple forms of cell death. Furthermore, SEL1L deficiency selectively disrupted naïve CD8+ T-cell homeostasis, as indicated by the severe loss of the naïve T-cell subset but an increase in the memory T-cell subset. We also found that SEL1L deficiency fueled mTORC1/c-MYC activation and induced a metabolic shift, which was largely attributable to enhanced expression of the IL-15 receptor α and β chains. Mechanistically, single-cell transcriptomic profiling and biochemical analyses further revealed that Sel1l−/− CD8+ T cells harbored excessive ER stress, particularly aberrant activation of the PERK-ATF4-CHOP-Bim pathway, which was alleviated by supplementing IL-7 or IL-15. Importantly, PERK inhibition greatly resolved the survival defects of Sel1l−/− CD8+ T cells. In addition, IRE1α deficiency decreased mTORC1 signaling in Sel1l−/− naïve CD8+ T cells by downregulating the IL-15 receptor α chain. Altogether, these observations suggest that the ERAD adaptor molecule SEL1L acts as an important checkpoint for preserving the survival and homeostasis of peripheral T cells by regulating the PERK signaling cascade and IL-15 receptor-mediated mTORC1 axis.
引用
收藏
页码:1232 / 1250
页数:18
相关论文
共 7 条
  • [1] SEL1L preserves CD8+ T-cell survival and homeostasis by fine-tuning PERK signaling and the IL-15 receptor-mediated mTORC1 axis
    Gao, Yafeng
    Li, Wenhui
    Wang, Zhenghao
    Zhang, Cangang
    He, Yaping
    Liu, Xiaowei
    Tang, Kexin
    Zhang, Weiguo
    Long, Qiaoming
    Liu, Yong
    Zhang, Jinping
    Zhang, Baojun
    Zhang, Lianjun
    CELLULAR & MOLECULAR IMMUNOLOGY, 2023, 20 (10) : 1232 - 1250
  • [2] IL-15 Trans-Signaling with the Superagonist RLI Promotes Effector/Memory CD8+ T Cell Responses and Enhances Antitumor Activity of PD-1 Antagonists
    Desbois, Melanie
    Le Vu, Pauline
    Coutzac, Clelia
    Marcheteau, Elie
    Beal, Coralie
    Terme, Magali
    Gey, Alain
    Morisseau, Sebastien
    Teppaz, Geraldine
    Boselli, Lisa
    Jacques, Yannick
    Bechard, David
    Tartour, Eric
    Cassard, Lydie
    Chaput, Nathalie
    JOURNAL OF IMMUNOLOGY, 2016, 197 (01): : 168 - 178
  • [3] Aberrant CD8+ T-Cell Responses and Memory Differentiation upon Viral Infection of an Ataxia-Telangiectasia Mouse Model Driven by Hyper-Activated Akt and mTORC1 Signaling
    D'Souza, Anthony D.
    Parish, Ian A.
    McKay, Sharen E.
    Kaech, Susan M.
    Shadel, Gerald S.
    AMERICAN JOURNAL OF PATHOLOGY, 2011, 178 (06): : 2740 - 2751
  • [4] Effects of Anti-PD-L1 or IL-15/IL-15Ra-Fc Complex Treatment on CD4-independent CD8+T Cell-Mediated Skin Allograft Rejection
    Elzein, Steven
    Su, Xiaojun
    Zhou, Dawei
    Sun, Si
    Strahs, Samson Hennessy-
    Minze, Laurie
    Xiao, Xiang
    Li, Xian
    AMERICAN JOURNAL OF TRANSPLANTATION, 2025, 25 (01)
  • [5] Enhanced NK and CD8+ T cell proliferation, tumor cytotoxicity and reversal of T cell exhaustion with IGM-7354, an anti-PD-L1 IgM antibody and IL-15 cytokine fusion
    Giffon, Thierry
    Desbois, Melanie
    Yakkundi, Poonam
    Sekar, Keerthana
    Manlusoc, Marigold
    Rosete, Rodnie
    Machado, Daniel
    Calhoun, Susan
    Kothambawala, Tasnim
    Ng, Dean
    Tran, Vu
    Saini, Avneesh
    Jain, Abhinav
    Wang, Beatrice
    Kotturi, Maya
    Keyt, Bruce
    Sinclair, Angus
    CANCER RESEARCH, 2022, 82 (12)
  • [6] IGM-7354, an immunocytokine with IL-15 fused to an anti-PD-L1 IgM, induces NK and CD8+T cell mediated cytotoxicity of PD-L1-positive tumor cells
    Giffon, Thierry D.
    Desbois, Melanie
    Yakkundi, Poonam
    Calhoun, Susan
    Sekar, Keerthana
    Denson, Carolyn
    Kothambawala, Tasnim
    Pearson, Alexander
    Pandey, Sivani
    Pandya, Deepal
    Rosete, Rodnie
    Machado, Daniel
    Raichlen, Pat
    Ng, Dean
    Jain, Abhinav R.
    Funke, Roel
    Humke, Eric
    Hinton, Paul R.
    Wang, Beatrice
    Keyt, Bruce A.
    Kotturi, Maya F.
    Sinclair, Angus M.
    CANCER RESEARCH, 2023, 83 (07)
  • [7] Results from a First-in-Human Study with Bnz-1: A Novel Peptide Inhibitor of IL-2, IL9 and IL-15 for the Treatment of T-Cell Malignancies That Safely and Selectively Decreases Regulatory T-Cells, Natural Killer Cells, and CD8+ Central Memory T-Cells
    Frohna, Paul
    Tagaya, Yutaka
    Ratnayake, Anoshie
    Doerr, Nick
    Basheer, Asjad
    Al-Mawsawi, Laith
    Kim, Woo Jae
    Zapata, Juan
    Wu, Xisorong
    Azimi, Nazli
    BLOOD, 2017, 130